Intelligence · Patent portfolio
United Therapeutics Europe Patents
Full USPTO pharma patent portfolio for United Therapeutics Europe — grant dates, expiration, and drug cross-links.
- Patents
- 3,720
- Expiring ≤24m
- 234
Quick answer
United Therapeutics Europe has 3,720 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 234 expire within 24 months — use filters for patent-cliff planning.
-
US 6110490
Liposomal delivery system for biologically active agents
expired -
US 6110465
Nucleotide and deduced amino acid sequences of hypervariable region 1 of the envelope 2 gene of isolates of hepatitis C virus and the use of reagents derived from these hypervariable sequences in diagnostic methods and vaccines
expired -
US 6107021
Synthetic peptide vaccines for foot-and-mouth disease
expired -
US 6103271
Microencapsulation and electrostatic processing method
expired -
US 6103235
Methods of inducing immune tolerance using immunotoxins
expired -
US 6103694
Method of decreasing radiation of radio-mimetic chemotherapy for hematopoietic pluripotent cell engraftment
expired -
US 6099847
Chimeric Gag pseudovirions
expired -
US 6099864
In situ activation of microcapsules
expired -
US 6099842
Recombinant immunotoxin composed of a single chain antibody reacting with the human transferrin receptor and diptheria toxin
expired -
US 6096534
Retrovirus vectors derived from avian sarcoma leukosis viruses permitting transfer of genes into mammalian cells
expired -
US 6096734
Photosensitizers for sensitizing cells
expired -
US 6093702
Mixtures of dideoxy-nucleosides and hydroxycarbamide for inhibiting retroviral spread
expired -
US 6093406
Vaccine for induction of immunity to malaria
expired -
US 6090795
Human derived monocyte attracting purified peptide products useful in a method of treating infection and neoplasms in a human body
expired -
US 6090388
Peptide composition for prevention and treatment of HIV infection and immune disorders
expired -
US 6087110
Alternative open reading frame DNA of a normal gene and a novel human cancer antigen encoded therein
expired -
US 6083503
Interleukin-2 stimulated T lymphocyte cell death for the treatment of autoimmune diseases, allergic responses, and graft rejection
expired -
US 6084090
Human papilloma virus anti-sense oligonucleotides
expired -
US 6084069
Autotaxin: motility stimulating protein useful in cancer diagnosis and therapy
expired -
US 6084063
Signal transduction inhibitors of allergic reactions
expired -
US 6083703
Identification of TRP-2 as a human tumor antigen recognized by cytotoxic T lymphocytes
expired -
US 6083502
Mesothelium antigen and methods and kits for targeting it
expired -
US 6077935
Acquired immune deficiency syndrome (AIDS) viral envelope protein and method of testing for AIDS
expired -
US 6074644
Nucleic acids encoding immunotoxins containing a disulfide-stabilized antibody fragment replacing half or more of domain IB of pseudomonas exotoxin, and methods of use of the encoded immunotoxins
expired -
US 6074864
Cloned DNA for synthesizing unique glucocerebrosidase
expired -
US 6074865
Recombinant dengue virus DNA fragment
expired -
US 6072031
Cellular apoptosis susceptibility protein (CSP)
expired -
US 6071709
Nerve growth factor/receptor complex
expired -
US 6071949
Use of lipoxygenase inhibitors as anti-cancer therapeutic and intervention agents
expired -
US 6068844
Increased resistance to stroke by developing immunologic tolerance to myelin or components thereof
expired -
US 6066642
Dihydropyridine-, pyridine-, benzopyran-4-one- and triazoloquinazoline derivative, their preparation and their use as adenosine receptor antagonists
expired -
US 6066323
Use of antibodies to sialidase as anti-infectious agents and anti-inflammatory agents
expired -
US 6066623
Polynucleotide vaccine protective against malaria, methods of protection and vector for delivering polynucleotide vaccines
expired -
US 6066656
2,5-diamino-3,4-disubstituted-1,6-diphenylhexane isosteres comprising benzamide, sulfonamide and anthranilamide subunits and methods of using same
expired -
US 6063371
Pharmaceutical compositions comprising a soluble interleukin-4 receptor
expired -
US 6063905
Recombinant human IGA-J. chain dimer
expired -
US 6060458
Oligodeoxyribonucleotides comprising O.sup.6 -benzylguanine and their use
expired -
US 6060310
Transcription factor decoy and tumor growth inhibitor
expired -
US 6060505
Method of treating cancer using C-26 modified bryostatin
expired -
US 6057298
Keratin K1 expression vectors and methods of use
expired -
US 6056952
Selective elimination of T cells that recognize specific preselected targets
expired -
US 6057346
Inhibition of retroviral LTR promoters by calcium response modifiers
expired -
US 6054486
Use of 9-Deoxy-2',9-.alpha.-methano-3-oxa-4,5,6-trinor-3,7-(1',3'-interphenylen e)-13,14-dihydro-prostaglandin f.sub.1 to treat peripheral vascular disease
expired -
US 6054567
Recombinant proteins of a pakistani strain of hepatitis E and their use in diagnostic methods and vaccines
expired -
US 6051214
Shampoos and conditioners containing estolides
expired -
US 6051549
Heparin and sulfatide binding peptides from the type-I repeats of human thrombospondin and conjugates thereof
expired -
US 6051405
Constructs encoding recombinant antibody-toxin fusion proteins
expired -
US 6048538
Peptides derived from the non-structural proteins of foot and mouth disease virus as diagnostic reagents
expired
Frequently asked questions
How many patents does United Therapeutics Europe have?
3,720 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do United Therapeutics Europe patents expire?
234 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.
Where does this data come from?
USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.
Data attribution: Data sources · Patent directory